Study identifies potential approach to treat patients with severe COVID-19

ScienceDaily
Jun 5, 2020, 2:05 pm211 pts
Early data from a clinical study suggest that blocking the Bruton tyrosine kinase (BTK) protein provided clinical benefit to a small group of patients with severe COVID-19. Researchers observed that the off-label use of the cancer drug acalabrutinib, a BTK inhibitor that is approved to treat several blood…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Largest turtle nest in the world revealed in drone study 249

Utility-Scale Solar Can Withstand Severe Hailstorms. Here’s How 123

BLUETTI Elite 100 V2 Portable Power Station — CleanTechnica Tested 119

Chevy is the fastest-growing EV brand for a reason: These deals are hard to pass up 118

Wheel-E Podcast: Boost’s flat e-bikes, Dahon IPO, LiveWire sale, more 116

From the Great Stink to the modern sewage scandal: Why 19th-century sewers are failing 21st-century England 115

The New Ti7: BYD’s $25,000 Premium SUV PHEV Destroys Remaining Justifications for Pure ICE 114

Toyota’s new flagship EV is, honestly, pretty impressive 109

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.